BioNTech SE 2022 SR
The report highlights BioNTech's 2022 progress in transitioning to a global immunotherapy leader, focusing on democratizing access to mRNA technology through its BioNTainer initiative. The company reported shipping 550 million variant-adapted vaccine doses and advancing its oncology pipeline to 20 clinical programs. BioNTech committed to a 1.5 degree Celsius pathway, submitting targets to the SBTi to reduce Scope 1 and 2 emissions by 42% by 2030. Socially, the workforce grew to 4,692 employees from over 80 nations, and the company appointed its first Human Rights Officer. The report also details significant economic contributions to its German home cities through tax revenues.
Company: BioNTech SE
Sector: Professional & technical services
Country: Germany
Year: 2022
Type: SR
Pages: 103
BioNTech SE
The report highlights BioNTech's 2022 progress in transitioning to a global immunotherapy leader, focusing on democratizing access to mRNA technology through its BioNTainer initiative. The company reported shipping 550 million variant-adapted vaccine doses and advancing its oncology pipeline to 20 clinical programs. BioNTech committed to a 1.5 degree Celsius pathway, submitting targets to the SBTi to reduce Scope 1 and 2 emissions by 42% by 2030. Socially, the workforce grew to 4,692 employees from over 80 nations, and the company appointed its first Human Rights Officer. The report also details significant economic contributions to its German home cities through tax revenues.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Mar 27, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees